Skip to main content

BIOLIFE SOLUTIONS INC

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

BLFS$38.61+3.5%Stored close · as of Oct 5, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

Year Ended December 31,
(In thousands)202520242023
Cash flows from operating activities
Net loss$(4,595)$(20,184)$(68,002)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Impairment of intangible assets——5,758
Impairment of long-lived assets——9,727
Gain on settlement of Global Cooling escrow——(5,115)
Depreciation2,2535,1607,114
Amortization of intangible assets2,4343,5015,181
Amortization of loan costs——13
Stock-based compensation22,99330,92333,245
Non-cash lease expense1,875424404
Deferred income tax expense (benefit)65(64)(62)
Change in fair value of contingent consideration——(2,193)
Change in fair value of equity investment and other(983)4,074—
Accretion of investments(736)(474)(1,262)
Loss on disposal of assets held for rent, net510567594
Loss on disposal of property and equipment, net11154633
IPR&D expense15,521——
Net gain on disposal of subsidiaries(10,324)(15,877)—
Change in operating assets and liabilities
Accounts receivable, trade, net264(2,899)15,351
Inventories(1,268)781(8,552)
Prepaid expenses and other current assets(3,039)(2,407)137
Accounts payable(2,086)26(8,425)
Accrued expenses and other current liabilities(1,144)6,4852,002
Sales taxes payable(1,905)(973)1,311
Warranty liability5(528)(454)
Other264(258)97
Net cash provided by (used in) operating activities20,1158,431(12,498)
Cash flows from investing activities
Purchases of property and equipment(9,478)(3,227)(6,381)
Purchases of assets held for rent(886)(2,068)(4,856)
Proceeds from sale of available-for-sale securities6,8293,5183,469
Maturities of available-for-sale securities34,76418,40052,700
Investment in available-for-sale securities(114,063)(18,415)(27,095)
Purchases of intangible assets—(300)—
Investment in IPR&D(10,221)——
Investment in convertible promissory note(2,000)——
Proceeds from sale of divested entities23,51673,431—
Payments on divestiture of Global Cooling—(13,039)—
Net cash (used in) provided by investing activities(71,539)58,30017,837
Cash flows from financing activities
Payments on term loan(10,000)(5,000)(300)
Payments on equipment loans—(1,608)(198)
Issuance of common stock——10,244
Proceeds from exercise of common stock options18202507
Proceeds from financed insurance premium—2,0942,639
Payments on financed insurance premium(975)(2,397)(2,365)
Other33(74)64
Net cash (used in) provided by financing activities(10,924)(6,783)10,591
Net (decrease) increase in cash and cash equivalents(62,348)59,94815,930
Cash and cash equivalents – beginning of period95,38635,43819,473
Effects of currency translation on cash and cash equivalents——35
Cash and cash equivalents – end of period$33,038$95,386$35,438
Non-cash investing and financing activities
Assets acquired under operating leases$—$5,833$880
Assets acquired under finance leases$—$—$1,682
Purchase of property and equipment not yet paid$—$107$359
Unrealized loss (gain) on available-for-sale securities$108$(18)$(56)
Unrealized gain on currency translation$—$—$(12)
Non-cash acquisition of PanTHERA$5,300$—$—
Cashless issuance of SciSafe earnout shares$—$—$2,263
Returned shares from settlement of Global Cooling escrow$—$—$(5,115)
Cash interest paid$762$1,608$1,927
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.